Shared more. Cited more. Safe forever.
    • advanced search
    • submit works
    • about
    • help
    • contact us
    • login
    View Item 
    •   MOspace Home
    • University of Missouri-Columbia
    • College of Agriculture, Food and Natural Resources (MU)
    • Division of Applied Social Sciences (MU)
    • Department of Agricultural Economics (MU)
    • Economics and Management of Agrobiotechnology Center (MU)
    • AgBioForum (Journal)
    • AgBioForum, vol. 13, no.1 (2010)
    • View Item
    •   MOspace Home
    • University of Missouri-Columbia
    • College of Agriculture, Food and Natural Resources (MU)
    • Division of Applied Social Sciences (MU)
    • Department of Agricultural Economics (MU)
    • Economics and Management of Agrobiotechnology Center (MU)
    • AgBioForum (Journal)
    • AgBioForum, vol. 13, no.1 (2010)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    advanced searchsubmit worksabouthelpcontact us

    Browse

    All of MOspaceCommunities & CollectionsDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis SemesterThis CollectionDate IssuedAuthor/ContributorTitleIdentifierThesis DepartmentThesis AdvisorThesis Semester

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular AuthorsStatistics by Referrer

    Cost of Compliance with Biotechnology Regulation in the Philippines : Implications for Developing Countries

    Bayer, Jessica C.
    Norton, George W.
    Falck-Zepeda, José Benjamin
    View/Open
    [PDF] CostComplianceBiotechnologyReg.pdf (166.0Kb)
    Date
    2010
    Format
    Article
    Metadata
    [+] Show full item record
    Abstract
    Direct and opportunity costs of regulation are presented for four transgenic products in the Philippines: Bt eggplant, Bt rice, ringspot-virus-resistant papaya, and virus-resistant tomatoes. Understanding the magnitude of these costs is important for evaluating potential net benefits of genetically modified crops, both for countries that are designing their regulatory procedures and for those implementing them. Results indicate that direct regulatory costs are significant but generally smaller than technology development costs. However, the cost of foregone benefits stemming from even a relatively brief delay in product release, which might be due to unexpected regulatory delays, overshadows both research and regulatory costs. Regulatory systems must ensure that none of the steps in its regulatory process for GM products that are required to protect public safety and the environment are omitted, but unnecessary steps are costly. Direct regulatory costs appear to be declining within countries as they gain experience with more products.
    URI
    http://hdl.handle.net/10355/7070
    Citation
    AgBioForum, 13(1) 2010: 53-62.
    Rights
    OpenAccess.
    This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.
    Collections
    • AgBioForum, vol. 13, no.1 (2010)

    Send Feedback
    hosted by University of Missouri Library Systems
     

     


    Send Feedback
    hosted by University of Missouri Library Systems